Cargando…
Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Hematology
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368761/ https://www.ncbi.nlm.nih.gov/pubmed/37067945 http://dx.doi.org/10.1182/bloodadvances.2023009911 |
| _version_ | 1785077575328989184 |
|---|---|
| author | Al Tabaa, Yassine Casasnovas, Rene Oliver Baillet, Clio Bachy, Emmanuel Nicolas-Virelizier, Emmanuelle Schiano De colella, Jean Marc Bailly, Clement Kanoun, Salim Guidez, Stéphanie Gyan, Emmanuel Gressin, Remy Morineau, Nadine Ysebaert, Loic Le Gouill, Steven Tilly, Herve Houot, Roch Morschhauser, F. Cartron, Guillaume Herbaux, Charles |
| author_facet | Al Tabaa, Yassine Casasnovas, Rene Oliver Baillet, Clio Bachy, Emmanuel Nicolas-Virelizier, Emmanuelle Schiano De colella, Jean Marc Bailly, Clement Kanoun, Salim Guidez, Stéphanie Gyan, Emmanuel Gressin, Remy Morineau, Nadine Ysebaert, Loic Le Gouill, Steven Tilly, Herve Houot, Roch Morschhauser, F. Cartron, Guillaume Herbaux, Charles |
| author_sort | Al Tabaa, Yassine |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10368761 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | The American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103687612023-07-27 Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group Al Tabaa, Yassine Casasnovas, Rene Oliver Baillet, Clio Bachy, Emmanuel Nicolas-Virelizier, Emmanuelle Schiano De colella, Jean Marc Bailly, Clement Kanoun, Salim Guidez, Stéphanie Gyan, Emmanuel Gressin, Remy Morineau, Nadine Ysebaert, Loic Le Gouill, Steven Tilly, Herve Houot, Roch Morschhauser, F. Cartron, Guillaume Herbaux, Charles Blood Adv Research Letter The American Society of Hematology 2023-04-18 /pmc/articles/PMC10368761/ /pubmed/37067945 http://dx.doi.org/10.1182/bloodadvances.2023009911 Text en © 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Research Letter Al Tabaa, Yassine Casasnovas, Rene Oliver Baillet, Clio Bachy, Emmanuel Nicolas-Virelizier, Emmanuelle Schiano De colella, Jean Marc Bailly, Clement Kanoun, Salim Guidez, Stéphanie Gyan, Emmanuel Gressin, Remy Morineau, Nadine Ysebaert, Loic Le Gouill, Steven Tilly, Herve Houot, Roch Morschhauser, F. Cartron, Guillaume Herbaux, Charles Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group |
| title | Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group |
| title_full | Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group |
| title_fullStr | Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group |
| title_full_unstemmed | Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group |
| title_short | Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group |
| title_sort | prospective evaluation of lymphoma response to immunomodulatory therapy criteria in gata trial from the lysa group |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368761/ https://www.ncbi.nlm.nih.gov/pubmed/37067945 http://dx.doi.org/10.1182/bloodadvances.2023009911 |
| work_keys_str_mv | AT altabaayassine prospectiveevaluationoflymphomaresponsetoimmunomodulatorytherapycriteriaingatatrialfromthelysagroup AT casasnovasreneoliver prospectiveevaluationoflymphomaresponsetoimmunomodulatorytherapycriteriaingatatrialfromthelysagroup AT bailletclio prospectiveevaluationoflymphomaresponsetoimmunomodulatorytherapycriteriaingatatrialfromthelysagroup AT bachyemmanuel prospectiveevaluationoflymphomaresponsetoimmunomodulatorytherapycriteriaingatatrialfromthelysagroup AT nicolasvirelizieremmanuelle prospectiveevaluationoflymphomaresponsetoimmunomodulatorytherapycriteriaingatatrialfromthelysagroup AT schianodecolellajeanmarc prospectiveevaluationoflymphomaresponsetoimmunomodulatorytherapycriteriaingatatrialfromthelysagroup AT baillyclement prospectiveevaluationoflymphomaresponsetoimmunomodulatorytherapycriteriaingatatrialfromthelysagroup AT kanounsalim prospectiveevaluationoflymphomaresponsetoimmunomodulatorytherapycriteriaingatatrialfromthelysagroup AT guidezstephanie prospectiveevaluationoflymphomaresponsetoimmunomodulatorytherapycriteriaingatatrialfromthelysagroup AT gyanemmanuel prospectiveevaluationoflymphomaresponsetoimmunomodulatorytherapycriteriaingatatrialfromthelysagroup AT gressinremy prospectiveevaluationoflymphomaresponsetoimmunomodulatorytherapycriteriaingatatrialfromthelysagroup AT morineaunadine prospectiveevaluationoflymphomaresponsetoimmunomodulatorytherapycriteriaingatatrialfromthelysagroup AT ysebaertloic prospectiveevaluationoflymphomaresponsetoimmunomodulatorytherapycriteriaingatatrialfromthelysagroup AT legouillsteven prospectiveevaluationoflymphomaresponsetoimmunomodulatorytherapycriteriaingatatrialfromthelysagroup AT tillyherve prospectiveevaluationoflymphomaresponsetoimmunomodulatorytherapycriteriaingatatrialfromthelysagroup AT houotroch prospectiveevaluationoflymphomaresponsetoimmunomodulatorytherapycriteriaingatatrialfromthelysagroup AT morschhauserf prospectiveevaluationoflymphomaresponsetoimmunomodulatorytherapycriteriaingatatrialfromthelysagroup AT cartronguillaume prospectiveevaluationoflymphomaresponsetoimmunomodulatorytherapycriteriaingatatrialfromthelysagroup AT herbauxcharles prospectiveevaluationoflymphomaresponsetoimmunomodulatorytherapycriteriaingatatrialfromthelysagroup |